Rodriguez Carlos J, Swett Katrina, Agarwal Sunil K, Folsom Aaron R, Fox Ervin R, Loehr Laura R, Ni Hanyu, Rosamond Wayne D, Chang Patricia P
Department of Medicine and Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina.
Departments of Medicine and Epidemiology, Johns Hopkins University, Baltimore, Maryland.
JAMA Intern Med. 2014 Aug;174(8):1252-61. doi: 10.1001/jamainternmed.2014.2482.
Studies document a progressive increase in heart disease risk as systolic blood pressure (SBP) rises above 115 mm Hg, but it is unknown whether an SBP lower than 120 mm Hg among adults with hypertension (HTN) lowers heart failure, stroke, and myocardial infarction risk.
To examine the risk of incident cardiovascular (CV) events among adults with HTN according to 3 SBP levels: 140 mm Hg or higher; 120 to 139 mm Hg; and a reference level of lower than 120 mm Hg.
DESIGN, SETTING, AND PARTICIPANTS: A total of 4480 participants with HTN but without prevalent CV disease at baseline (years 1987-1989) from the Atherosclerosis Risk in Communities Study were included. Measurements of SBP were taken at baseline and at 3 triennial visits; SBP was treated as a time-dependent variable and categorized as elevated (≥140 mm Hg), standard (120-139 mm Hg), and low (<120 mm Hg). Multivariable Cox regression models included baseline age, sex, diabetes status, BMI, high cholesterol level, smoking status, and alcohol intake.
Incident composite CV events (heart failure, ischemic stroke, myocardial infarction, or death related to coronary heart disease).
After a median follow-up of 21.8 years, a total of 1622 incident CV events had occurred. Participants with elevated SBP developed incident CV events at a significantly higher rate than those in the low BP group (adjusted hazard ratio [HR], 1.46; 95% CI, 1.26-1.69). However, there was no difference in incident CV event-free survival among those in the standard vs low SBP group (adjusted HR, 1.00; 95% CI, 0.85-1.17). Further adjustment for BP medication use or diastolic BP did not significantly affect the results.
Among patients with HTN, having an elevated SBP carries the highest risk for cardiovascular events, but in this categorical analysis, once SBP was below 140 mm Hg, an SBP lower than 120 mm Hg did not appear to lessen the risk of incident CV events.
研究表明,随着收缩压(SBP)升至高于115 mmHg,心脏病风险会逐步增加,但高血压(HTN)成人中SBP低于120 mmHg是否能降低心力衰竭、中风和心肌梗死风险尚不清楚。
根据3个SBP水平检查高血压成人发生心血管(CV)事件的风险:140 mmHg或更高;120至139 mmHg;以及低于120 mmHg的参考水平。
设计、设置和参与者:共有4480名来自社区动脉粥样硬化风险研究的参与者,他们在基线时(1987 - 1989年)患有高血压但无普遍的心血管疾病。在基线和每三年一次的3次随访中测量SBP;SBP被视为一个随时间变化的变量,并分为升高(≥140 mmHg)、标准(120 - 139 mmHg)和低(<120 mmHg)。多变量Cox回归模型包括基线年龄、性别、糖尿病状态、BMI、高胆固醇水平、吸烟状态和酒精摄入量。
发生的复合CV事件(心力衰竭、缺血性中风、心肌梗死或与冠心病相关的死亡)。
在中位随访21.8年后,共发生了1622起CV事件。SBP升高的参与者发生CV事件的发生率明显高于低血压组(调整后的风险比[HR],1.46;95%CI,1.26 - 1.69)。然而,标准SBP组与低SBP组之间无CV事件生存差异(调整后的HR,1.00;95%CI,0.85 - 1.17)。进一步调整血压药物使用或舒张压对结果无显著影响。
在高血压患者中,SBP升高带来的心血管事件风险最高,但在此分类分析中,一旦SBP低于140 mmHg,低于120 mmHg的SBP似乎并未降低发生CV事件的风险。